A group 1 hemagglutinin stem vaccine elicits broad humoral responses against influenza in phase 1/2a study
Nina Hertoghs, Chan Tang, Vitalija van Paassen, Mandy Jongeneelen et autres
1 citationNature Communications
Harmjan Kuipers
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
42Publications signalées
3855Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Immune Cell Function and InteractionImmunotherapy and Immune ResponsesAsthma and respiratory diseasesInfluenza Virus Research StudiesAdvanced Chemical Physics Studies
Publications récentes
Plant Cell Culture-Derived Saponin Adjuvant Enhances Immune Response Against a Stabilized Human Metapneumovirus Pre-Fusion Vaccine Candidate
Maarten Swart, Jessica Allen, Brendan Reed, Ana Izquierdo Gil et autres
7 citationsVaccines
A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naïve non-human primates
Aneesh Vijayan, Ronald Vogels, Rachel Groppo, Yi Jin et autres
16 citationsNature Communications
Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity
Lucy Rutten, Maarten Swart, Annemart Koornneef, Pascale Bouchier et autres
17 citationsScientific Reports
Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen
Maarten Swart, Harmjan Kuipers, Fin Milder, Mandy Jongeneelen et autres
8 citationsnpj Vaccines
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2
Maarten Swart, Joan van der Lubbe, Sonja Schmit-Tillemans, Ella van Huizen et autres
5 citationsnpj Vaccines
Immunogenicity of an Ad26-based SARS-CoV-2 Omicron Vaccine in Naïve Mice and SARS-CoV-2 Spike Pre-immune Hamsters
Maarten Swart, Adriaan de Wilde, Sonja Schmit-Tillemans, Johan Verspuij et autres
2 citationsbioRxiv (Cold Spring Harbor Laboratory)
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP
Laura Solforosi, Harmjan Kuipers, Mandy Jongeneelen, Sietske K. Rosendahl Huber et autres
70 citationsThe Journal of Experimental Medicine
Immunogenicity and protective efficacy of one- and two-dose regimens of the Ad26.COV2.S COVID-19 vaccine candidate in adult and aged rhesus macaques
Laura Solforosi, Harmjan Kuipers, Sietske K. Rosendahl Huber, Joan E. M. van der Lubbe et autres
10 citationsbioRxiv (Cold Spring Harbor Laboratory)
Restrained expansion of the recall germinal center response as biomarker of protection for influenza vaccination in mice
Laurens P. Kil, Joost Vaneman, Joan E. M. van der Lubbe, Dominika N. Czapska-Casey et autres
5 citationsPLoS ONE
Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice
Joan E. M. van der Lubbe, Johan Verspuij, Jeroen Huizingh, Sonja Schmit-Tillemans et autres
29 citationsFrontiers in Immunology
Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge
Joan E. M. van der Lubbe, Jeroen Huizingh, Johan Verspuij, Lisanne Tettero et autres
27 citationsnpj Vaccines
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.